Bid Price | 2.65p | High Price | 2.80p |
---|
Ask Price | 2.70p | Low Price | 2.61p |
---|
Open Price | 2.75p | Spread | 1.85% |
---|
Prev Close | 2.75p | Volume | 1,431,859 |
---|
Shield Therapeutics PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Nov 8, 2024 | 2.75 | 2.80 | 2.70 | 2.75 | 640,215 |
Nov 7, 2024 | 2.75 | 2.77 | 2.71 | 2.75 | 129,787 |
Nov 6, 2024 | 2.75 | 2.80 | 2.70 | 2.75 | 1,316,748 |
Nov 5, 2024 | 2.80 | 2.80 | 2.64 | 2.75 | 1,540,809 |
Nov 4, 2024 | 3.00 | 3.00 | 2.70 | 2.80 | 2,724,588 |
More Shield Therapeutics PLC Historic Prices >Shield Therapeutics PLC Information
Name | Shield Therapeutics PLC | Index | FTSE AIM All Share |
---|
ISIN | GB00BYV81293 | Epic | STX |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
---|
EMS | 75,000 | Trading Status | Closed |
---|
Shares in Issue | 782.06 m | Prev Close | 2.75p |
---|
PE Ratio | 32.154341 | Market Cap | £20.92 m |
---|
Div Yield | 0 | Div per Share | $NaN |
---|
EPS | -$0.02 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | -0.503896 | DPS Growth (%) | 0 |
---|
Current Ratio | 1.048792 | Quick Ratio | 0.885611 |
---|
Shield Therapeutics PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
27/11/23 | BUY | Hans Hasler | NED | 2,000,000 @ £0.06 | £122,000.00 |
09/01/23 | PLAC | Hans Hasler | NED | 3,000,000 @ £0.06 | £180,000.00 |
09/01/23 | PLAC | Gregory Madison | RES | 1,359,434 @ £0.06 | £81,566.00 |
09/01/23 | PLAC | Christian Schweiger | NED | 4,486,133 @ £0.06 | £269,168.00 |
06/01/23 | PLAC | Maria Lacerca-Allen | NED | 271,886 @ £0.06 | £16,313.00 |
06/01/23 | PLAC | Gregory Madison | RES | 1,359,434 @ £0.06 | £81,566.00 |
06/01/23 | EXR | Gregory Madison | RES | 1,000,000 @ £0.02 | £15,000.00 |
06/01/23 | BUY | Peter Llewellyn-Davies | NED | 166,666 @ £0.06 | £10,000.00 |
06/01/23 | BUY | Christian Schweiger | NED | 4,486,133 @ £0.06 | £269,168.00 |
28/12/22 | SELL | Gregory Madison | RES | 466,395 @ £0.07 | £31,715.00 |
More Shield Therapeutics PLC Director Deals >Shield Therapeutics PLC News